Glucagon-like Peptide-1 Receptor Agonist Use May Reduce Disease Activity and Progression in Osteoarthritis and Inflammatory Arthritis

Orthopedic Clinics of North America · Published 2026-07-01 · DOI 10.1016/j.ocl.2026.05.004

Authors (3)

Maxwell Trudeau, Olivia Schaffer, Ran Schwarzkopf

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Trudeau, M., Schaffer, O., Schwarzkopf, R. (2026). Glucagon-like Peptide-1 Receptor Agonist Use May Reduce Disease Activity and Progression in Osteoarthritis and Inflammatory Arthritis. Orthopedic Clinics of North America. https://doi.org/10.1016/j.ocl.2026.05.004

Related articles